The development of pharmaceutical care at the warfarin clinic of patients in Plapak Hospital.

Abstract

Objective: (1) To develop the care process for patients with cardiovascular disease receiving warfarin in Plapak Hospital. And (2) to study the effectiveness of pharmaceutical care in the warfarin clinic for caring for patients with cardiovascular disease receiving warfarin in Plapak Hospital.

Materials and Method: The research and development model used a quasi-experimental data collection method using questionnaires 3 times during the study period of 3 months. The population used in the study is There were 78 patients with cardiovascular disease who used pharmaceutical care services in the warfarin clinic at Plapak Hospital. And the selection was made using non-probability sampling without using purposive sample that were processed with a ready-made program to search for descriptive and inferential statistics. The tools used in the study are Developing pharmaceutical care by adding steps for pharmacists to care for patients pre-counselling and post-counselling.

Result: The study found that Knowledge about warfarin significantly improved treatment efficacy by 0.000, 0.001, and 0.000, respectively. Because, the number of patients with cardiovascular disease who have knowledge and understanding about the correct use of warfarin continues to increase, accounting for 60.0%, 76.0%, and 89.0%, respectively. Meanwhile, patient behavior significantly increased treatment efficiency at 0.000, 0.005, and 0.000, respectively. Because, the increase in patients with cardiovascular disease who are able to control TTR values within the appropriate target range, accounting for 56.0%, 68.0% and 75.0%, respectively. The main reason why the patient's TTR value is not within the target range is patients forget or have problems with treatment costs. The patient did not take all the medicine according to the doctor's orders or at the prescribed time, respectively.

Conclusion: The development of pharmaceutical care improved treatment efficiency significantly by 0.005, 0.000, and 0.001, respectively. It can be said that the development of pharmaceutical care work by adding steps in which pharmacists care for patients pre-counselling and post-counselling. It is a treatment method that makes patients with cardiovascular disease who receive warfarin safe. and have an increased chance of success in treatment. Therefore, increasing knowledge about warfarin and improving the patient's behavior to be appropriate is therefore an important part of cooperation in using medicine that results in the patient's TTR being within the specified target.